Bliss GVS Pharma Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

22 Feb 2019 | 03:59 PM

177.95
8.90 (5.26%)

  • Underperforms Index

    -6.22%

    Return (1Y)

    Underperformed S&P BSE Healthcare by 3.55%

  • More Volatile

    2.62%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 1.5%

  • Not so consistent

    4/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

225

224.70

125

125.00

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Bliss GVS Pharma Ltd has increased by 75.44% since past 3 Months

  • Promoter shareholding in Bliss GVS Pharma Ltd has decreased by -16.11% since past 3 Months

  • FII shareholding in Bliss GVS Pharma Ltd has increased by 142.1% since past 1 Year

  • Promoter shareholding in Bliss GVS Pharma Ltd has decreased by -16.11% since past 1 Year

Loading...